Impact of red yeast rice supplementation on lipid profile: a systematic review and meta-analysis of randomized-controlled trials.
- 2022-10-25
- Expert review of clinical pharmacology 16(1)
- Parisa Rahmani
- Ebru Melekoglu
- Sogand Tavakoli
- Nasser Malekpour Alamdari
- Pejman Rohani
- Mohammad Hassan Sohouli
- PubMed: 36259545
- DOI: 10.1080/17512433.2023.2138342
Study Design
- Type
- Meta-Analysis
- Population
- adults with dyslipidemia
- Methods
- Four comprehensive databases (SCOPUS, PubMed/MEDLINE, EMBASE, and Web of Science) were employed until 23 December 2021 RCTs, with 24 treatment arms included after screening 3623 articles
- Duration
- less than 12 weeks
Background
Dyslipidemia/hyperlipidemia are among the risk factors for chronic diseases, especially cardiovascular diseases. Red Yeast Rice (RYR) herbal supplement may be helpful in improving serum fat levels due to some mechanisms. Therefore, the aim of this study was to evaluate the effects of RYR consumption on total serum cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels in adults.Research design and methods
Four comprehensive databases (SCOPUS, PubMed/MEDLINE, EMBASE, and Web of Science) were employed until 23 December 2021 RCTs, with 24 treatment arms included after screening 3623 articles.Results
Pooled data showed significant effectiveness in lowering TC (WMD: -33.16 mg/dl, 95% CI: -37.69, -28.63, P < 0.001), LDL-C (WMD: -28.94 mg/dl, 95% CI: -32.90, -24.99, P < 0.001), and TG (WMD: -23.36 mg/dl, 95% CI: -31.30, -15.43, P < 0.001) concentration and increasing HDL-C concentration (WMD: 2.49 mg/dl, 95% CI: 1.48, 3.49, P < 0.001) following RYR supplementation. Furthermore, the effect of this herbal drug in doses less than 1200 mg and with an intervention duration of less than 12 weeks was more in individuals with dyslipidemia.Conclusion
In conclusion, this comprehensive article and meta-analysis showed that RYR significantly decreases TC, TG, and LDL-C as well as increases HDL-C.Research Insights
increasing HDL-C concentration (WMD: 2.49 mg/dl, 95% CI: 1.48, 3.49, P < 0.001)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- less than 1200 mg
significant effectiveness in lowering TC (WMD: -33.16 mg/dl, 95% CI: -37.69, -28.63, P < 0.001)
- Effect
- Beneficial
- Effect size
- Large
- Dose
- less than 1200 mg
significant effectiveness in lowering LDL-C (WMD: -28.94 mg/dl, 95% CI: -32.90, -24.99, P < 0.001)
- Effect
- Beneficial
- Effect size
- Large
- Dose
- less than 1200 mg
significant effectiveness in lowering TG (WMD: -23.36 mg/dl, 95% CI: -31.30, -15.43, P < 0.001)
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- less than 1200 mg